Jung‐Mo Ahn

Optimal Dissociation Methods Differ for N - and O -Glycopeptides

Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer

Computerized Automated Reminder Diabetes System (CARDS): E-Mail and SMS Cell Phone Text Messaging Reminders to Support Diabetes Management

Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring

Breast-cancer detection using blood-based infrared molecular fingerprints

Recent Advances in Lectin-Based Affinity Sorbents for Protein Glycosylation Studies

Identification of proteomic signatures associated with lung cancer and COPD

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics

Glycoproteomics

Current literature in diabetes

Global and site‐specific analysis of protein glycosylation in complex biological systems with Mass Spectrometry

Proteomics biomarkers for solid tumors: Current status and future prospects

Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction

Proteoform Profile Mapping of the Human Serum Complement Component C9 Revealing Unexpected New Features of N-, O-, and C-Glycosylation

Effects of Recombinant Adenovirus-Mediated Uncoupling Protein 2 Overexpression on Endothelial Function and Apoptosis

Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**

The Haptoglobin β chain as a supportive biomarker for human lung cancers

Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer

Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells

Fucosylated glycoproteomic approach to identify a complement component 9 associated with squamous cell lung cancer (SQLC)

Meta-markers for the differential diagnosis of lung cancer and lung disease